» Articles » PMID: 20193126

Macrophage Inhibitory Cytokine-1 Transactivates ErbB Family Receptors Via the Activation of Src in SK-BR-3 Human Breast Cancer Cells

Overview
Journal BMB Rep
Date 2010 Mar 3
PMID 20193126
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The function of macrophage inhibitory cytokine-1 (MIC-1) in cancer remains controversial, and its signaling pathways remain poorly understood. In this study, we demonstrate that MIC-1 induces the transactivation of EGFR, ErbB2, and ErbB3 through the activation of c-Src in SK-BR-3 breast cells. MIC-1 induced significant phosphorylation of EGFR at Tyr845, ErbB2 at Tyr877, and ErbB3 at Tyr1289 as well as Akt and p38, Erk1/2, and JNK mitogen-activated protein kinases (MAPKs). Treatment of SK-BR-3 cells with MIC-1 increased the phosphorylation level of Src at Tyr416, and induced invasiveness of those cells. Inhibition of c-Src activity resulted in the complete abolition of MIC-1-induced phosphorylation of the EGFR, ErbB2, and ErbB3, as well as invasiveness and matrix metalloproteinase (MMP)-9 expression in SK-BR-3 cells. Collectively, these results show that MIC-1 may participate in the malignant progression of certain cancer cells through the activation of c-Src, which in turn may transactivate ErbB-family receptors.

Citing Articles

GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.

Xie B, Tang W, Wen S, Chen F, Yang C, Wang M Biomolecules. 2024; 14(1).

PMID: 38254638 PMC: 10813690. DOI: 10.3390/biom14010038.


Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.

Ganjoo S, Puebla-Osorio N, Nanez S, Hsu E, Voss T, Barsoumian H Front Immunol. 2022; 13:1033642.

PMID: 36353620 PMC: 9638036. DOI: 10.3389/fimmu.2022.1033642.


Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It.

Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hamai A Cells. 2021; 10(11).

PMID: 34831207 PMC: 8616391. DOI: 10.3390/cells10112981.


c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?.

Belli S, Esposito D, Servetto A, Pesapane A, Formisano L, Bianco R Cancers (Basel). 2020; 12(6).

PMID: 32517369 PMC: 7352780. DOI: 10.3390/cancers12061489.


Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.

Wischhusen J, Melero I, Fridman W Front Immunol. 2020; 11:951.

PMID: 32508832 PMC: 7248355. DOI: 10.3389/fimmu.2020.00951.